[Working group of Dermatologic Oncology ADO. Second-line therapy in stage IV melanoma].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D003880:Dermatology / Q000592:standards*; D005858:Germany; D006801:Humans; D008545:Melanoma / Q000188:drug therapy* / Q000473:pathology; D009367:Neoplasm Staging; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000592:standards; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology
D000970:Antineoplastic Agents; D003879:Dermatologic Agents